Literature DB >> 12036283

Molecular genetic methods in the diagnosis of hematologic neoplasms.

Filiz Sen1, Francisco Vega, L Jeffrey Medeiros.   

Abstract

Leukemias and lymphomas are monoclonal neoplasms that arise as a result of molecular abnormalities. These abnormalites are diverse but can be grouped into two general categories, chromosomal translocations that usually result in oncogene activation and inactivation of tumor suppressor genes. Recent advances in our understanding of chromosomal translocations have led to improved classification of leukemias and lymphomas. For example, the t(9;22)(q34;q11) is now considered a defining feature of chronic myeloid leukemia, and the t(2;5)(p23;q35) defines a clinically and biologically unique subset of anaplastic large cell lymphomas. In this review, we focus on chromosomal translocations in hematologic neoplasms and the techniques used for their detection. We also briefly discuss tumor suppressor genes and assessment of clonality in lymphoid neoplasms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036283

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  3 in total

1.  Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay.

Authors:  Young Kim; Yoo Duk Choi; Chan Choi; Jong-Hee Nam
Journal:  Korean J Pathol       Date:  2013-10-25

2.  Laboratory Diagnosis and Monitoring of Leukaemias and Lymphomas at Molecular Level.

Authors:  Renata Zadro
Journal:  EJIFCC       Date:  2005-05-17

3.  A New and Simple TRG Multiplex PCR Assay for Assessment of T-cell Clonality: A Comparative Study from the EuroClonality Consortium.

Authors:  Marine Armand; Coralie Derrieux; Kheira Beldjord; Tamara Wabeke; Dido Lenze; Elke Boone; Monika Bruggemann; Paul A S Evans; Paula Gameiro; Michael Hummel; Patrick Villarese; Patricia J T A Groenen; Anton W Langerak; Elizabeth A Macintyre; Frederic Davi
Journal:  Hemasphere       Date:  2019-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.